Lal S, Kiely M E, Thavundayil J X, Stewart J D, Assalian P, Ackman C F
Department of Psychiatry, Montreal General Hospital, Quebec, Canada.
J Psychiatry Neurosci. 1991 Dec;16(5):262-6.
An open pilot study was undertaken to investigate the therapeutic effect of the dopaminergic agent, bromocriptine (BC), in impotent patients who developed an erectile response to the dopamine receptor agonist, apomorphine. Eight out of 17 patients reported improvement in ability to obtain an erection; five of these 8 subjects were able to achieve penetration. The optimum dose of BC was 2.5 - 11.25 mg/day. A double-blind placebo-controlled study is merited.
开展了一项开放性试验研究,以调查多巴胺能药物溴隐亭(BC)对那些对多巴胺受体激动剂阿扑吗啡产生勃起反应的阳痿患者的治疗效果。17名患者中有8名报告勃起能力有所改善;这8名受试者中有5名能够完成性交插入。BC的最佳剂量为2.5 - 11.25毫克/天。值得进行一项双盲安慰剂对照研究。